Iqvia reports first-quarter 2025 results

Research triangle park, n.c.--(business wire)--iqvia holdings inc. (“iqvia”) (nyse:iqv), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended march 31, 2025. first-quarter 2025 operating results revenue for the first quarter of $3,829 million increased 2.5 percent on a reported basis and 3.5 percent at constant currency, compared to the first.
IQV Ratings Summary
IQV Quant Ranking